IOVS Journal of Clinical Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2007;48:571-582.)
© 2007 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0864

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolan, J. M.
Right arrow Articles by Beatty, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolan, J. M.
Right arrow Articles by Beatty, S.

The Relationships between Macular Pigment Optical Density and Its Constituent Carotenoids in Diet and Serum

John M. Nolan,1 Jim Stack,2 Eamonn O’Connell,3 and Stephen Beatty1,3

1From the Macular Pigment Research Group, Department of Chemical and Life Sciences and the 2Department of Physical and Quantitative Sciences, Waterford Institute of Technology, Waterford, Ireland; and the 3Department of Ophthalmology, Waterford Regional Hospital, Waterford, Ireland.

PURPOSE. Lutein (L) and zeaxanthin (Z) are two dietary carotenoids that accumulate at the macula, where they are collectively known as macular pigment (MP). There is a biologically plausible rationale, with some supporting evidence, that MP may protect against age-related maculopathy (ARM). This study was undertaken to investigate the relationship between dietary intake of L and Z, serum concentrations of these carotenoids, and MP optical density in 828 healthy Irish subjects.

METHODS. Dietary intake of L and Z was assessed with a validated food-frequency questionnaire, and serum concentrations of these carotenoids were quantified by high-performance liquid chromatography. MP optical density was measured psychophysically, using heterochromatic flicker photometry. Demographic data, lifestyle data, and general health status, were also recorded by questionnaire, with particular attention directed toward risk-factors (established and putative) for ARM.

RESULTS. The relationships between MP optical density, serum concentrations of L (and Z), and dietary intake of L (and Z) were positive and statistically significant when analyzed for the entire study group (r = 0.136–0.303; P < 0.01 for all). Subjects with a clinically confirmed family history of ARM, current heavy cigarette smokers, subjects aged more than 53 years, and subjects with a body mass index (BMI) >27, did not demonstrate a positive and significant relationship between MP optical density and serum concentrations of Z (r = 0.041, r = 0.001, r = 0.074 and r = 0.082, respectively; P > 0.05 for all). However, there was a positive and significant relationship between MP optical density and serum concentrations of L in the presence of all these risk factors (r = 0.165 to 0.257), except for current heavy smokers (r = 0.042; P > 0.05).

CONCLUSIONS. For subjects at increased risk of ARM (e.g., subjects with a clinically confirmed family history of ARM, current heavy cigarette smokers, subjects aged > 53 years and subjects with a BMI > 27) retinal capture and/or retinal stabilization of Z appears to be compromised, whereas retinal uptake and/or stabilization of L appears to be compromised in current heavy smokers only. Given the lack of MP in association with risk for ARM, the findings indicate that a retina predisposed to this condition may have an impaired ability to accumulate circulating Z.





This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
L. Zhao and B. V. Sweet
Lutein and zeaxanthin for macular degeneration
Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1232 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. D O'Connell, J. M Nolan, J. Stack, D. Greenberg, J. Kyle, L. Maddock, and S. Beatty
Diet and risk factors for age-related maculopathy
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 712 - 722.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. E. Connor, P. B. Duell, R. Kean, and Y. Wang
The Prime Role of HDL to Transport Lutein into the Retina: Evidence from HDL-Deficient WHAM Chicks Having a Mutant ABCA1 Transporter
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4226 - 4231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Association for Research in Vision and Ophthalmology